Berlin, Germany

Heike Ziebarth

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Heike Ziebarth: Innovator in DNA Fragmentation Techniques

Introduction

Heike Ziebarth is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of molecular biology, particularly in the area of DNA extraction from archived samples. With a total of 2 patents to her name, her work has the potential to advance genetic research and diagnostics.

Latest Patents

Heike Ziebarth's latest patents focus on methods for providing DNA fragments derived from archived samples, such as paraffin-embedded and fixed-tissue biopsies. These innovative methods ensure high yields of DNA, with a substantial portion consisting of long DNA fragments. The isolated genomic DNA is free from associated contaminants, including proteins, peptides, amino acids, or RNA. The techniques are designed to be facile, cost-effective, and characterized by high reproducibility and reliability. Notably, the yield of DNA before amplification is at least 20%, and amplicons can reach lengths of about 1,000 base pairs.

Career Highlights

Heike Ziebarth is currently associated with Epigenomics AG, where she continues to develop her groundbreaking methods. Her expertise in DNA extraction has positioned her as a key figure in the field, contributing to advancements that can significantly impact medical research and diagnostics.

Collaborations

Heike has collaborated with notable colleagues, including Matthias Ballhause and Kurt Berlin. These partnerships have fostered an environment of innovation and have led to the development of her patented techniques.

Conclusion

Heike Ziebarth's contributions to DNA fragmentation methods represent a significant advancement in molecular biology. Her work not only enhances the efficiency of DNA extraction but also opens new avenues for research and clinical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…